German biotech firm BioNTech reported a loss of €665.3 million ($721 million) in 2024, as demand for its COVID-19 vaccines fell, according to the company’s financial results report on Monday.
The company, which posted a €930.3 million profit in 2023, failed to make a profit in a fiscal year…
Leave a Reply